Abiopharma

🔍 Patel Sanjiv (Executive)

Company: Relay Therapeutics, Inc. (RLAY)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Acquired 994 shares of Common Stock at $2.99 per share (Direct)
  Date: 2025-12-31 | Code: A | equity_swap_involved: false | shares_owned_after: 704,209.00 | transaction_form_type: 5 | Footnotes: F1, F2, F3
• Sold 43,168 shares of Common Stock at $7.82 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: false | shares_owned_after: 661,041.00 | transaction_form_type: 4 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-06 | Code: H | nature_of_ownership: By The Patel Family Irrevocable Trust of 2019 | shares_owned_after: 199,548.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-06 | Code: H | nature_of_ownership: By The SSP Irrevocable Trust of 2020 | shares_owned_after: 687,355.00 | Footnotes: F6

Footnotes:

• F1: The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.
• F2: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025.
• F3: Includes 136,854 shares underlying restricted stock units ("RSUs").
• F4: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,854 shares of RSUs on January 5, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
• F5: These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• F6: These shares were held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.